

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 6.39919501 |
| 2 | proteasome assembly (GO:0043248) | 5.71955408 |
| 3 | regulation of mitochondrial translation (GO:0070129) | 5.18453478 |
| 4 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.61658597 |
| 5 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.57132658 |
| 6 | GDP-mannose metabolic process (GO:0019673) | 4.55553450 |
| 7 | iron-sulfur cluster assembly (GO:0016226) | 4.40061042 |
| 8 | metallo-sulfur cluster assembly (GO:0031163) | 4.40061042 |
| 9 | protein maturation by protein folding (GO:0022417) | 4.34662639 |
| 10 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.29777825 |
| 11 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.29360177 |
| 12 | negative regulation of ligase activity (GO:0051352) | 4.29360177 |
| 13 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.13973896 |
| 14 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.13957874 |
| 15 | chaperone-mediated protein transport (GO:0072321) | 4.08355194 |
| 16 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.04759929 |
| 17 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.01223469 |
| 18 | respiratory electron transport chain (GO:0022904) | 3.99116034 |
| 19 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.90008354 |
| 20 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.90008354 |
| 21 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.89147347 |
| 22 | electron transport chain (GO:0022900) | 3.89106488 |
| 23 | base-excision repair, AP site formation (GO:0006285) | 3.88050977 |
| 24 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.86387247 |
| 25 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.86387247 |
| 26 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.86387247 |
| 27 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.82161073 |
| 28 | ATP synthesis coupled proton transport (GO:0015986) | 3.81397790 |
| 29 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.81397790 |
| 30 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.78830524 |
| 31 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.78830524 |
| 32 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.73567307 |
| 33 | mitochondrial calcium ion transport (GO:0006851) | 3.72457477 |
| 34 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.71983829 |
| 35 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.71983829 |
| 36 | protein complex biogenesis (GO:0070271) | 3.71011814 |
| 37 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.68444391 |
| 38 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.66479041 |
| 39 | deoxyribonucleotide catabolic process (GO:0009264) | 3.65446002 |
| 40 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.63970385 |
| 41 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.63747027 |
| 42 | protein targeting to mitochondrion (GO:0006626) | 3.57200791 |
| 43 | positive regulation of ligase activity (GO:0051351) | 3.53989742 |
| 44 | deoxyribose phosphate catabolic process (GO:0046386) | 3.53348318 |
| 45 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.46763878 |
| 46 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.44162182 |
| 47 | regulation of cellular amine metabolic process (GO:0033238) | 3.44096957 |
| 48 | nucleotide salvage (GO:0043173) | 3.43721069 |
| 49 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.41466680 |
| 50 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.38961761 |
| 51 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.38430397 |
| 52 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.36221106 |
| 53 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.34589256 |
| 54 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.34375304 |
| 55 | rRNA modification (GO:0000154) | 3.33429646 |
| 56 | cytochrome complex assembly (GO:0017004) | 3.30946303 |
| 57 | establishment of protein localization to mitochondrion (GO:0072655) | 3.28632174 |
| 58 | purine nucleotide salvage (GO:0032261) | 3.26778535 |
| 59 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.26124734 |
| 60 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.24181879 |
| 61 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.24181879 |
| 62 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.23691890 |
| 63 | pentose metabolic process (GO:0019321) | 3.22922932 |
| 64 | deoxyribose phosphate metabolic process (GO:0019692) | 3.21510491 |
| 65 | regulation of ligase activity (GO:0051340) | 3.21316176 |
| 66 | protein deneddylation (GO:0000338) | 3.21240117 |
| 67 | nucleoside salvage (GO:0043174) | 3.20805854 |
| 68 | oxidative phosphorylation (GO:0006119) | 3.16260292 |
| 69 | respiratory chain complex IV assembly (GO:0008535) | 3.16055327 |
| 70 | GTP biosynthetic process (GO:0006183) | 3.15062455 |
| 71 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.14764869 |
| 72 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.14764869 |
| 73 | NADH dehydrogenase complex assembly (GO:0010257) | 3.14764869 |
| 74 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.12056113 |
| 75 | L-phenylalanine metabolic process (GO:0006558) | 3.12056113 |
| 76 | protein retention in ER lumen (GO:0006621) | 3.11884024 |
| 77 | protein localization to mitochondrion (GO:0070585) | 3.09660227 |
| 78 | GMP metabolic process (GO:0046037) | 3.09095447 |
| 79 | positive regulation of cell cycle arrest (GO:0071158) | 3.06577476 |
| 80 | autophagic vacuole fusion (GO:0000046) | 3.03494607 |
| 81 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.03276763 |
| 82 | pyrimidine-containing compound salvage (GO:0008655) | 3.02665138 |
| 83 | pyrimidine nucleoside salvage (GO:0043097) | 3.02665138 |
| 84 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.01230845 |
| 85 | cullin deneddylation (GO:0010388) | 2.95333179 |
| 86 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.94327943 |
| 87 | pseudouridine synthesis (GO:0001522) | 2.94133912 |
| 88 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.93247648 |
| 89 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.93159424 |
| 90 | termination of RNA polymerase III transcription (GO:0006386) | 2.93159424 |
| 91 | DNA deamination (GO:0045006) | 2.92785687 |
| 92 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.92512686 |
| 93 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.92070882 |
| 94 | deoxyribonucleotide metabolic process (GO:0009262) | 2.91812016 |
| 95 | DNA strand elongation (GO:0022616) | 2.90517950 |
| 96 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.89694276 |
| 97 | negative regulation of B cell apoptotic process (GO:0002903) | 2.89556928 |
| 98 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.89117216 |
| 99 | UTP biosynthetic process (GO:0006228) | 2.88075532 |
| 100 | nuclear envelope reassembly (GO:0031468) | 2.87342241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.65437417 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.59092479 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.57095700 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.28765492 |
| 5 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.16689403 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.11100630 |
| 7 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.75254757 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.74552872 |
| 9 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.65972176 |
| 10 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.65954553 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.61776753 |
| 12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.48219381 |
| 13 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.46440187 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.45206361 |
| 15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.38195230 |
| 16 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.34450416 |
| 17 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.25980413 |
| 18 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.09841581 |
| 19 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.08588067 |
| 20 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.04049346 |
| 21 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.96676642 |
| 22 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.96534456 |
| 23 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.94248278 |
| 24 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.93676746 |
| 25 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.89392070 |
| 26 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.89140411 |
| 27 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.86828979 |
| 28 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.82361077 |
| 29 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.75800330 |
| 30 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.75462430 |
| 31 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.74218861 |
| 32 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.70149626 |
| 33 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.69375410 |
| 34 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.67344686 |
| 35 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.66505455 |
| 36 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66438319 |
| 37 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.61547697 |
| 38 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.61456034 |
| 39 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.57573817 |
| 40 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.56329461 |
| 41 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.55476585 |
| 42 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.52991637 |
| 43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.52473853 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.51652441 |
| 45 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.50821035 |
| 46 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.50692961 |
| 47 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.46689399 |
| 48 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46142131 |
| 49 | * P68_20966046_ChIP-Seq_HELA_Human | 1.45854226 |
| 50 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.45570562 |
| 51 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.44621105 |
| 52 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.42841188 |
| 53 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.38836497 |
| 54 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.38146698 |
| 55 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.36667166 |
| 56 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.34657088 |
| 57 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.34464123 |
| 58 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.33572266 |
| 59 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.31451508 |
| 60 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.29921202 |
| 61 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.29463473 |
| 62 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.28301331 |
| 63 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.25425794 |
| 64 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.25308350 |
| 65 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.25308159 |
| 66 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.23786782 |
| 67 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.22999854 |
| 68 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.19237473 |
| 69 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.18045929 |
| 70 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.17458835 |
| 71 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.17438138 |
| 72 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.17293873 |
| 73 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.16782868 |
| 74 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.16104311 |
| 75 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.14645282 |
| 76 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14464039 |
| 77 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14119899 |
| 78 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.13872367 |
| 79 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.12222174 |
| 80 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.11444944 |
| 81 | SA1_27219007_Chip-Seq_Bcells_Human | 1.11203990 |
| 82 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.10782758 |
| 83 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.10130263 |
| 84 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.08823446 |
| 85 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.08049713 |
| 86 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.07764273 |
| 87 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.07244128 |
| 88 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.06036578 |
| 89 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05907287 |
| 90 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05800299 |
| 91 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.03717144 |
| 92 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.03335686 |
| 93 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03151727 |
| 94 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.02557873 |
| 95 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.02287780 |
| 96 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.00991252 |
| 97 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.00980542 |
| 98 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.99813157 |
| 99 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.97892956 |
| 100 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97667632 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 6.32789810 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.73236241 |
| 3 | MP0006036_abnormal_mitochondrial_physio | 3.68726166 |
| 4 | MP0003186_abnormal_redox_activity | 3.27999508 |
| 5 | MP0005410_abnormal_fertilization | 2.98935531 |
| 6 | MP0003786_premature_aging | 2.97066679 |
| 7 | MP0008058_abnormal_DNA_repair | 2.88559613 |
| 8 | MP0005670_abnormal_white_adipose | 2.83236336 |
| 9 | MP0005451_abnormal_body_composition | 2.79363134 |
| 10 | MP0000372_irregular_coat_pigmentation | 2.77235695 |
| 11 | MP0006035_abnormal_mitochondrial_morpho | 2.30090398 |
| 12 | MP0009697_abnormal_copulation | 2.17725436 |
| 13 | MP0002132_abnormal_respiratory_system | 2.15734109 |
| 14 | MP0003693_abnormal_embryo_hatching | 2.12939030 |
| 15 | MP0008007_abnormal_cellular_replicative | 1.99585742 |
| 16 | MP0008260_abnormal_autophagy | 1.96471098 |
| 17 | MP0003111_abnormal_nucleus_morphology | 1.95779195 |
| 18 | MP0001764_abnormal_homeostasis | 1.91266099 |
| 19 | MP0008875_abnormal_xenobiotic_pharmacok | 1.88457447 |
| 20 | MP0000678_abnormal_parathyroid_gland | 1.87767123 |
| 21 | MP0001905_abnormal_dopamine_level | 1.87675368 |
| 22 | MP0008932_abnormal_embryonic_tissue | 1.82270718 |
| 23 | MP0009840_abnormal_foam_cell | 1.79047659 |
| 24 | MP0000358_abnormal_cell_content/ | 1.70605337 |
| 25 | MP0003718_maternal_effect | 1.69563573 |
| 26 | MP0010094_abnormal_chromosome_stability | 1.67914373 |
| 27 | MP0003077_abnormal_cell_cycle | 1.58522038 |
| 28 | MP0001661_extended_life_span | 1.58465007 |
| 29 | MP0004957_abnormal_blastocyst_morpholog | 1.54820876 |
| 30 | MP0005332_abnormal_amino_acid | 1.47289370 |
| 31 | MP0000681_abnormal_thyroid_gland | 1.47013675 |
| 32 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.40525526 |
| 33 | MP0005330_cardiomyopathy | 1.38948684 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.38468473 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.33608061 |
| 36 | MP0004233_abnormal_muscle_weight | 1.32224451 |
| 37 | MP0003011_delayed_dark_adaptation | 1.28419580 |
| 38 | MP0005075_abnormal_melanosome_morpholog | 1.25096750 |
| 39 | MP0005319_abnormal_enzyme/_coenzyme | 1.24511492 |
| 40 | MP0000749_muscle_degeneration | 1.22397094 |
| 41 | MP0004147_increased_porphyrin_level | 1.20493818 |
| 42 | MP0001853_heart_inflammation | 1.18106714 |
| 43 | MP0009278_abnormal_bone_marrow | 1.17966712 |
| 44 | MP0000747_muscle_weakness | 1.17811348 |
| 45 | MP0008995_early_reproductive_senescence | 1.17324673 |
| 46 | MP0002139_abnormal_hepatobiliary_system | 1.17323465 |
| 47 | MP0002736_abnormal_nociception_after | 1.14334058 |
| 48 | MP0001929_abnormal_gametogenesis | 1.12085149 |
| 49 | MP0001529_abnormal_vocalization | 1.11696105 |
| 50 | MP0000343_altered_response_to | 1.11364076 |
| 51 | MP0002019_abnormal_tumor_incidence | 1.08104303 |
| 52 | MP0003698_abnormal_male_reproductive | 1.08080317 |
| 53 | MP0003646_muscle_fatigue | 1.07923318 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.07257818 |
| 55 | MP0000750_abnormal_muscle_regeneration | 1.06415598 |
| 56 | MP0005464_abnormal_platelet_physiology | 1.06142851 |
| 57 | MP0001727_abnormal_embryo_implantation | 1.05953494 |
| 58 | MP0001881_abnormal_mammary_gland | 1.05431221 |
| 59 | MP0000751_myopathy | 1.04570019 |
| 60 | MP0003878_abnormal_ear_physiology | 1.02692103 |
| 61 | MP0005377_hearing/vestibular/ear_phenot | 1.02692103 |
| 62 | MP0003137_abnormal_impulse_conducting | 1.00814516 |
| 63 | MP0002269_muscular_atrophy | 1.00413365 |
| 64 | MP0000313_abnormal_cell_death | 0.97213292 |
| 65 | MP0002148_abnormal_hypersensitivity_rea | 0.96773188 |
| 66 | MP0005636_abnormal_mineral_homeostasis | 0.96585761 |
| 67 | MP0008873_increased_physiological_sensi | 0.95207662 |
| 68 | MP0005083_abnormal_biliary_tract | 0.95128144 |
| 69 | MP0000858_altered_metastatic_potential | 0.92675921 |
| 70 | MP0003075_altered_response_to | 0.89074357 |
| 71 | MP0005266_abnormal_metabolism | 0.87460002 |
| 72 | MP0009643_abnormal_urine_homeostasis | 0.83313472 |
| 73 | MP0005379_endocrine/exocrine_gland_phen | 0.83117297 |
| 74 | MP0004145_abnormal_muscle_electrophysio | 0.82718194 |
| 75 | MP0002163_abnormal_gland_morphology | 0.81886839 |
| 76 | MP0001968_abnormal_touch/_nociception | 0.81374908 |
| 77 | MP0005365_abnormal_bile_salt | 0.80286874 |
| 78 | MP0002249_abnormal_larynx_morphology | 0.80030170 |
| 79 | MP0005367_renal/urinary_system_phenotyp | 0.79274324 |
| 80 | MP0000516_abnormal_urinary_system | 0.79274324 |
| 81 | MP0001545_abnormal_hematopoietic_system | 0.79095119 |
| 82 | MP0005397_hematopoietic_system_phenotyp | 0.79095119 |
| 83 | MP0008469_abnormal_protein_level | 0.77885597 |
| 84 | MP0002161_abnormal_fertility/fecundity | 0.73639254 |
| 85 | MP0001243_abnormal_dermal_layer | 0.73341258 |
| 86 | MP0005360_urolithiasis | 0.73276594 |
| 87 | MP0002234_abnormal_pharynx_morphology | 0.71720331 |
| 88 | MP0000759_abnormal_skeletal_muscle | 0.71150477 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.65420015 |
| 90 | MP0002210_abnormal_sex_determination | 0.64313298 |
| 91 | MP0001145_abnormal_male_reproductive | 0.64130539 |
| 92 | MP0001730_embryonic_growth_arrest | 0.62023789 |
| 93 | MP0002837_dystrophic_cardiac_calcinosis | 0.61877203 |
| 94 | MP0002722_abnormal_immune_system | 0.60783687 |
| 95 | MP0000598_abnormal_liver_morphology | 0.58735535 |
| 96 | MP0000653_abnormal_sex_gland | 0.58486157 |
| 97 | MP0005501_abnormal_skin_physiology | 0.58329750 |
| 98 | MP0005646_abnormal_pituitary_gland | 0.58305979 |
| 99 | MP0009764_decreased_sensitivity_to | 0.57752647 |
| 100 | MP0002970_abnormal_white_adipose | 0.57647900 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.27293717 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 4.92101534 |
| 3 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.72170095 |
| 4 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.72170095 |
| 5 | Mitochondrial inheritance (HP:0001427) | 4.57798667 |
| 6 | Acute encephalopathy (HP:0006846) | 4.54275401 |
| 7 | Hepatocellular necrosis (HP:0001404) | 4.48493032 |
| 8 | Increased intramyocellular lipid droplets (HP:0012240) | 4.30579949 |
| 9 | Increased CSF lactate (HP:0002490) | 4.19882706 |
| 10 | Hepatic necrosis (HP:0002605) | 4.15170165 |
| 11 | Increased muscle lipid content (HP:0009058) | 4.13412138 |
| 12 | Progressive macrocephaly (HP:0004481) | 3.82694967 |
| 13 | Type I transferrin isoform profile (HP:0003642) | 3.60435943 |
| 14 | Cerebral edema (HP:0002181) | 3.54366000 |
| 15 | Ragged-red muscle fibers (HP:0003200) | 3.50369385 |
| 16 | Lactic acidosis (HP:0003128) | 3.33121319 |
| 17 | Hyperthyroidism (HP:0000836) | 3.14398489 |
| 18 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.13630400 |
| 19 | Abnormal protein glycosylation (HP:0012346) | 3.13630400 |
| 20 | Abnormal glycosylation (HP:0012345) | 3.13630400 |
| 21 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.13630400 |
| 22 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.13409233 |
| 23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.13409233 |
| 24 | Abnormality of glycolipid metabolism (HP:0010969) | 3.13409233 |
| 25 | Exercise intolerance (HP:0003546) | 3.11595067 |
| 26 | Respiratory failure (HP:0002878) | 3.05710307 |
| 27 | Truncus arteriosus (HP:0001660) | 3.05471543 |
| 28 | Opisthotonus (HP:0002179) | 3.03808635 |
| 29 | Renal Fanconi syndrome (HP:0001994) | 3.01617006 |
| 30 | Abnormal gallbladder physiology (HP:0012438) | 3.00167638 |
| 31 | Cholecystitis (HP:0001082) | 3.00167638 |
| 32 | Hypokinesia (HP:0002375) | 2.96666755 |
| 33 | Increased serum lactate (HP:0002151) | 2.95302318 |
| 34 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.93970614 |
| 35 | Lipid accumulation in hepatocytes (HP:0006561) | 2.80296225 |
| 36 | Spastic paraparesis (HP:0002313) | 2.79860073 |
| 37 | Hypertensive crisis (HP:0100735) | 2.75367192 |
| 38 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.73063844 |
| 39 | Dicarboxylic aciduria (HP:0003215) | 2.73063844 |
| 40 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.71503181 |
| 41 | Increased hepatocellular lipid droplets (HP:0006565) | 2.68040764 |
| 42 | Petechiae (HP:0000967) | 2.64553372 |
| 43 | Emotional lability (HP:0000712) | 2.61865487 |
| 44 | Rhabdomyolysis (HP:0003201) | 2.59390521 |
| 45 | Reduced antithrombin III activity (HP:0001976) | 2.58915374 |
| 46 | Seborrheic dermatitis (HP:0001051) | 2.56015107 |
| 47 | Cerebral hypomyelination (HP:0006808) | 2.55719569 |
| 48 | Testicular atrophy (HP:0000029) | 2.53674220 |
| 49 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.51044491 |
| 50 | Progressive microcephaly (HP:0000253) | 2.48921401 |
| 51 | Progressive muscle weakness (HP:0003323) | 2.47052347 |
| 52 | Microvesicular hepatic steatosis (HP:0001414) | 2.43713142 |
| 53 | Vertebral compression fractures (HP:0002953) | 2.42308125 |
| 54 | Cerebral palsy (HP:0100021) | 2.39916721 |
| 55 | CNS demyelination (HP:0007305) | 2.39185325 |
| 56 | Aplastic anemia (HP:0001915) | 2.36091356 |
| 57 | Generalized aminoaciduria (HP:0002909) | 2.34791584 |
| 58 | Lethargy (HP:0001254) | 2.34021434 |
| 59 | Abnormality of glycolysis (HP:0004366) | 2.32242323 |
| 60 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.30607624 |
| 61 | Muscle fiber atrophy (HP:0100295) | 2.27143805 |
| 62 | Myoglobinuria (HP:0002913) | 2.27117271 |
| 63 | Respiratory difficulties (HP:0002880) | 2.24721731 |
| 64 | Increased serum pyruvate (HP:0003542) | 2.24581301 |
| 65 | Degeneration of anterior horn cells (HP:0002398) | 2.21715113 |
| 66 | Abnormality of the anterior horn cell (HP:0006802) | 2.21715113 |
| 67 | Rough bone trabeculation (HP:0100670) | 2.18358172 |
| 68 | Progressive neurologic deterioration (HP:0002344) | 2.17532370 |
| 69 | Microretrognathia (HP:0000308) | 2.17069924 |
| 70 | Pancytopenia (HP:0001876) | 2.12539384 |
| 71 | 3-Methylglutaconic aciduria (HP:0003535) | 2.11712647 |
| 72 | Chronic obstructive pulmonary disease (HP:0006510) | 2.08868120 |
| 73 | Obstructive lung disease (HP:0006536) | 2.08868120 |
| 74 | Retinal dysplasia (HP:0007973) | 2.02726570 |
| 75 | Methylmalonic aciduria (HP:0012120) | 2.02457985 |
| 76 | Severe visual impairment (HP:0001141) | 2.01615109 |
| 77 | Myopathic facies (HP:0002058) | 2.00122703 |
| 78 | Prolonged neonatal jaundice (HP:0006579) | 1.99318236 |
| 79 | Vacuolated lymphocytes (HP:0001922) | 1.96982446 |
| 80 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.91512415 |
| 81 | Cholelithiasis (HP:0001081) | 1.91169684 |
| 82 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.90664459 |
| 83 | Neoplasm of head and neck (HP:0012288) | 1.90369139 |
| 84 | Esophageal neoplasm (HP:0100751) | 1.90369139 |
| 85 | Nemaline bodies (HP:0003798) | 1.89502183 |
| 86 | Trismus (HP:0000211) | 1.89028744 |
| 87 | Leukodystrophy (HP:0002415) | 1.86627795 |
| 88 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.85939603 |
| 89 | Abnormality of the tricuspid valve (HP:0001702) | 1.83990966 |
| 90 | Atelectasis (HP:0100750) | 1.83043399 |
| 91 | Delusions (HP:0000746) | 1.82332109 |
| 92 | Type 2 muscle fiber atrophy (HP:0003554) | 1.81760303 |
| 93 | Hyperammonemia (HP:0001987) | 1.81531168 |
| 94 | Gliosis (HP:0002171) | 1.80879363 |
| 95 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.78894034 |
| 96 | Exertional dyspnea (HP:0002875) | 1.78625918 |
| 97 | Abnormal gallbladder morphology (HP:0012437) | 1.75481458 |
| 98 | Nonimmune hydrops fetalis (HP:0001790) | 1.73600674 |
| 99 | Optic disc pallor (HP:0000543) | 1.73108327 |
| 100 | Vomiting (HP:0002013) | 1.72933514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK2 | 4.53843083 |
| 2 | NME2 | 4.29052673 |
| 3 | BCKDK | 4.22437625 |
| 4 | TESK1 | 3.87115916 |
| 5 | VRK2 | 3.79803444 |
| 6 | BUB1 | 3.28953257 |
| 7 | KDR | 3.06222606 |
| 8 | MAP3K11 | 2.75554432 |
| 9 | NME1 | 2.22897301 |
| 10 | LIMK1 | 2.15762319 |
| 11 | PBK | 2.12934421 |
| 12 | ARAF | 1.97698047 |
| 13 | PIM2 | 1.96880840 |
| 14 | SCYL2 | 1.94613975 |
| 15 | MAP4K2 | 1.84489238 |
| 16 | ABL2 | 1.84356010 |
| 17 | MAP3K12 | 1.82133330 |
| 18 | ZAK | 1.73385229 |
| 19 | STK16 | 1.70691909 |
| 20 | MAPKAPK3 | 1.70191689 |
| 21 | DAPK1 | 1.67210290 |
| 22 | MUSK | 1.67008319 |
| 23 | SRPK1 | 1.27364909 |
| 24 | CDC7 | 1.27236397 |
| 25 | IRAK3 | 1.23016864 |
| 26 | MYLK | 1.21635114 |
| 27 | VRK1 | 1.21283832 |
| 28 | AURKA | 1.20980644 |
| 29 | TAOK2 | 1.17218152 |
| 30 | TLK1 | 1.16784331 |
| 31 | CSNK1G3 | 1.07051534 |
| 32 | EPHA2 | 1.05819487 |
| 33 | PAK4 | 1.04441350 |
| 34 | ERN1 | 0.97216610 |
| 35 | MAP3K3 | 0.95781041 |
| 36 | TBK1 | 0.92692687 |
| 37 | NEK1 | 0.91147341 |
| 38 | PLK4 | 0.91080588 |
| 39 | CDK19 | 0.89466394 |
| 40 | MAP2K7 | 0.88800429 |
| 41 | ILK | 0.86439088 |
| 42 | BRSK1 | 0.84231499 |
| 43 | PAK1 | 0.83902743 |
| 44 | MAP4K1 | 0.82131136 |
| 45 | BRAF | 0.81625668 |
| 46 | CCNB1 | 0.81135246 |
| 47 | RPS6KA5 | 0.79047188 |
| 48 | CAMK2G | 0.77665519 |
| 49 | LRRK2 | 0.75807613 |
| 50 | DAPK3 | 0.73022885 |
| 51 | INSRR | 0.72699741 |
| 52 | PRKD3 | 0.70554759 |
| 53 | IRAK2 | 0.69518594 |
| 54 | PAK6 | 0.69045477 |
| 55 | PLK1 | 0.68804870 |
| 56 | CSNK1A1L | 0.68631150 |
| 57 | DYRK2 | 0.68461755 |
| 58 | CHEK2 | 0.64421336 |
| 59 | CSNK1G1 | 0.63496407 |
| 60 | PDK2 | 0.63214995 |
| 61 | TRIM28 | 0.60675900 |
| 62 | TXK | 0.58247789 |
| 63 | CSNK1G2 | 0.57065238 |
| 64 | TTK | 0.56563421 |
| 65 | TYK2 | 0.56266054 |
| 66 | CDK7 | 0.53543752 |
| 67 | AURKB | 0.53276187 |
| 68 | EIF2AK1 | 0.52352547 |
| 69 | RPS6KA4 | 0.51830612 |
| 70 | MAP3K8 | 0.49896512 |
| 71 | ATR | 0.49177600 |
| 72 | FLT3 | 0.48372660 |
| 73 | TIE1 | 0.47725662 |
| 74 | TNK2 | 0.46836971 |
| 75 | PRKCI | 0.45595145 |
| 76 | CDK14 | 0.45126614 |
| 77 | NUAK1 | 0.44348740 |
| 78 | FES | 0.42431705 |
| 79 | MAP2K2 | 0.41996510 |
| 80 | RPS6KB2 | 0.41519350 |
| 81 | CSNK2A1 | 0.41372130 |
| 82 | CDK8 | 0.41025119 |
| 83 | CDK11A | 0.39586204 |
| 84 | SMG1 | 0.38419310 |
| 85 | MAP2K3 | 0.37602362 |
| 86 | OBSCN | 0.37185301 |
| 87 | GRK6 | 0.36512037 |
| 88 | RAF1 | 0.36466621 |
| 89 | MAP3K1 | 0.35182226 |
| 90 | TRIB3 | 0.32574568 |
| 91 | CDK15 | 0.31734490 |
| 92 | CSNK2A2 | 0.31273342 |
| 93 | MAPK11 | 0.30750073 |
| 94 | ZAP70 | 0.29870738 |
| 95 | CDK18 | 0.29724091 |
| 96 | AKT2 | 0.28306046 |
| 97 | PKN1 | 0.27981763 |
| 98 | PHKG2 | 0.25901674 |
| 99 | PHKG1 | 0.25901674 |
| 100 | GRK5 | 0.25508752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.88993372 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.42175246 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.04469185 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 2.97031343 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 2.72747383 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.66139289 |
| 7 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.65359295 |
| 8 | Sulfur relay system_Homo sapiens_hsa04122 | 2.52842733 |
| 9 | Ribosome_Homo sapiens_hsa03010 | 2.44034204 |
| 10 | Mismatch repair_Homo sapiens_hsa03430 | 2.42265169 |
| 11 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.26542828 |
| 12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.19822030 |
| 13 | RNA polymerase_Homo sapiens_hsa03020 | 2.18362824 |
| 14 | Huntingtons disease_Homo sapiens_hsa05016 | 2.06820186 |
| 15 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.89418485 |
| 16 | Alzheimers disease_Homo sapiens_hsa05010 | 1.87321742 |
| 17 | Homologous recombination_Homo sapiens_hsa03440 | 1.77131409 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.76392981 |
| 19 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.71355931 |
| 20 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.70934673 |
| 21 | Carbon metabolism_Homo sapiens_hsa01200 | 1.70401688 |
| 22 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.66981368 |
| 23 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.58257182 |
| 24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.54102371 |
| 25 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.50456642 |
| 26 | Other glycan degradation_Homo sapiens_hsa00511 | 1.48845389 |
| 27 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.41076701 |
| 28 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.40616059 |
| 29 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.39241774 |
| 30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.37902935 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.36628706 |
| 32 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.36056600 |
| 33 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.34475816 |
| 34 | Galactose metabolism_Homo sapiens_hsa00052 | 1.33858805 |
| 35 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.32541841 |
| 36 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.27156235 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.24849157 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.18149995 |
| 39 | Purine metabolism_Homo sapiens_hsa00230 | 1.14751207 |
| 40 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.12656229 |
| 41 | Peroxisome_Homo sapiens_hsa04146 | 1.12363886 |
| 42 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.11830050 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.10643483 |
| 44 | Spliceosome_Homo sapiens_hsa03040 | 1.06636680 |
| 45 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.05411728 |
| 46 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.04702633 |
| 47 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.04147647 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.03147173 |
| 49 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.02311677 |
| 50 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.01348105 |
| 51 | Metabolic pathways_Homo sapiens_hsa01100 | 0.99867354 |
| 52 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.99391991 |
| 53 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.98471641 |
| 54 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.96217889 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93647741 |
| 56 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.91559758 |
| 57 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.91183622 |
| 58 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.86882745 |
| 59 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.84957018 |
| 60 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.84317228 |
| 61 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.81914853 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.80560641 |
| 63 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.80175788 |
| 64 | Lysosome_Homo sapiens_hsa04142 | 0.79656100 |
| 65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.77965486 |
| 66 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.74563960 |
| 67 | RNA transport_Homo sapiens_hsa03013 | 0.73342726 |
| 68 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.71611113 |
| 69 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.70801408 |
| 70 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.70718775 |
| 71 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.66052811 |
| 72 | Protein export_Homo sapiens_hsa03060 | 0.61691243 |
| 73 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.61288587 |
| 74 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.58777527 |
| 75 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.57770891 |
| 76 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54728114 |
| 77 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.54139666 |
| 78 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.49962900 |
| 79 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.48641517 |
| 80 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.47116429 |
| 81 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.45247669 |
| 82 | Shigellosis_Homo sapiens_hsa05131 | 0.36332252 |
| 83 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.32648891 |
| 84 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.29648422 |
| 85 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.29553752 |
| 86 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.29193008 |
| 87 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.28694914 |
| 88 | Retinol metabolism_Homo sapiens_hsa00830 | 0.27038017 |
| 89 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.26360547 |
| 90 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23428565 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.23208704 |
| 92 | Cell cycle_Homo sapiens_hsa04110 | 0.22057301 |
| 93 | RNA degradation_Homo sapiens_hsa03018 | 0.20018977 |
| 94 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.19623967 |
| 95 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.19482127 |
| 96 | Salmonella infection_Homo sapiens_hsa05132 | 0.16294406 |
| 97 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.15581046 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.14024896 |
| 99 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.12339977 |
| 100 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.11515026 |

